Guardant Health (GH) Tops Q3 EPS by 29c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Guardant Health (GH) PT Raised to $60 at Leerink Partners
November 7, 2024 5:56 AM ESTLeerink Partners analyst Puneet Souda raised the price target on Guardant Health (NASDAQ: GH) to $60.00 (from $50.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: GH addressed two major questions weighing on the shares heading into the quarter: (1) slowdown in its... More
